Evidence Supports Removing Restrictions on Mifepristone
What: A JAMA op-ed outlines mifepristone’s safety and argues that rules like prescriber certification are unnecessary and deter access.
Key Line: “Instead of benefiting patients, the Prescriber Agreement Form is a barrier… 9% of OB-GYNs cited it as a reason they didn’t offer the service.”
Source: JAMA
A $10M program aims to train 25,000 providers in menopause and midlife care.
A study found racial disparities in complication risks among women with prior C-sections, with Black and Latino women facing higher risks during planned repeat surgeries.
Women’s Health breaks down what happens when you stop taking the pill.
The Atlantic explains the MAHA movement’s mysterious focus on the mitochondria, a tiny structure in cells that generate energy.
A small study shows it’s the lack of *uninterrupted* sleep—not just less sleep—that derails postpartum recovery.
Pew survey shows support often mirrors politics—except in a few swing states.
The New York Times profiles older women struggling with anorexia, with limited treatment options and serious long-term health consequences.
CDC finds sharp increases in alcohol-related liver deaths—especially in women and Native communities.
Scripps researchers found female rats’ brain chemistry made them more sensitive to alcohol.
Nearly half of women in a study chose to continue hormone therapy beyond the standard 5 years.
Kailyn McCord writes for *The Cut* about her postpartum pelvic prolapse being dismissed for months.
Researchers found the rate of vaginal hysterectomy has dropped significantly and is projected to decrease even further by 2030.
A new study finds 12–20% of women had visited crisis pregnancy centers.
A validated maternal risk score accurately flags risk of severe outcomes.
The Trump administration withdrew rules requiring hospitals to provide emergency abortions.
A meta-analysis finds that navigation services significantly boost breast and cervical cancer screening.
Politico has the scoop on HHS defending its reversal on pregnancy vaccine guidance by citing studies that show the vaccines are safe.
Some newly appointed CDC vaccine panelists have past ties to anti-vaccine movements.
Under pressure from conservatives, the FDA promised to review mifepristone, though experts have dismissed the evidence being used as deeply flawed.
States like Texas are updating abortion laws—but doctors say confusion remains.